Pages
Ads
Categories
- Allergies pills
- Anthelmintics
- Anti Convulsants Pills
- Anti Depressants Pills
- Antibiotics Pills
- AntiViralPill
- Arthritis pills
- Blood Pressure Pills
- Cholesterol Pills
- Diabetes Pills
- Diuretics pills
- eBook download
- Erectile Dysfunction Pills
- Gastrointestinal Pills
- Heartburn Pills
- herbal
- Hypertension pills
- Images pills
- Inflammatory
- Mens Health pills
- Muscle Relaxant Pills
- News
- Other pills
- Pain Relief Pills
- Review prices
- Skin Care Pills
- Stop Smoking Pills
- Uncategorized
- Video about ED pills
- Weight Loss Pills
- Women's Health Drugs
Blogroll
- Acomplia blog
- Advanced whois
- Buy Generic Zofran (Ondansetron)
- Buy Pills Online
- Cialis vs Levitra
- Diet Recipes Blog
- Flexyx A-Z drugs
- Generic Cialis soft tabs
- German drugstore
- Health News and Articles
- Health Signal
- Home Health Agencies
- Italian drugstore
- Natural Weight Loss
- Net Pharmacy
- Spanish drugstore
- The Canadian Rx Drugs
- Traumatology and Orthopaedics
- Viagra Mastercard
- Viagra Without Prescription
- FDA Approves Bayer HealthCare's Kogenate FS Treatment for Routine Prophylaxis in Children with Hemophilia A
- FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US
- FDA Approves New Injection Site for Risperdal Consta for Schizophrenia Treatment
- Watson Receives US FDA Approval for Rapaflo (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
- Akorn, Inc. Announces the FDA Approval of Akten Ophthalmic Gel 3.5%
- U.S. Food & Drug Administration Approved the use of Reyataz (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- FDA Grants Lilly's Alimta (Pemetrexed for Injection) Third U.S. Approval
- Boston Scientific Announces FDA Approval of TAXUS Express2 Atom Stent System, First Drug-Eluting Stent For Small Vessels
- Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
- FDA Approves Nasacort AQ Nasal Spray for Children Aged 2-5 years old
Tags
ads
Tamiflu or Oseltamivir
November 9, 2007
Tamiflu is used for the treatment of uncomplicated acute illness due to influenza infection.
How Taken
You may take Tamiflu with or without food. However, when taken with food, your tolerability to Tamiflu may be enhanced. The recommended oral dose of Tamiflu is 75 mg twice daily for 5 days. You should begin treatment within 2 days of onset of symptoms of influenza.
Warnings/Precautions
Tamiflu is not a substitute for a flu vaccination. You should continue receiving an annual flu vaccination. It is not known whether this medicine is excreted in human milk. You should therefore, use this drug only if the potential benefit justifies the potential risk to the breast-fed infant.
Missed Dose
If you miss a dose, use it as soon as you remember. If it is near the time for the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Possible Side Effects
You may experience some common, less serious side effects: nausea (without vomiting), vomiting, diarrhea, abdominal pain, dizziness, headache, cough, insomnia, fatigue.
Storage
Store Tamiflu under refrigeration at 36º to 46ºF (2º to 8ºC). Do not freeze.
Overdose
Symptoms of a Tamiflu overdose are nausea and/or vomiting. Seek medical attention if an overdose is suspected.
More Information
You should begin treatment with Tamiflu as soon as possible from the first appearance of flu symptoms. Similarly, prevention should begin as soon as possible after exposure, at the recommendation of a physician.
Disclaimer
This drug information is for your information purposes only, it is not intended that this information covers all uses, directions, drug interactions, precautions, or adverse effects of your medication. This is only general information, and should not be relied on for any purpose. It should not be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the accuracy and reliability of this information, and/or any consequences arising from the use of this information, including damage or adverse consequences to persons or property, however such damages or consequences arise. No warranty, either expressed or implied, is made in regards to this information
From Wikidedia
Clinical use
Indications and dosage
Oseltamivir is indicated for the treatment of infections due to influenza A and B virus in people at least one year of age, and prevention of influenza in people at least one year and older. The usual adult dosage for treatment of influenza is 75 mg twice daily for 5 days, beginning within 2 days of the appearance of symptoms and with decreased doses for children and patients with renal impairment. Oseltamivir may be given as a preventive measure either during a community outbreak or following close contact with an infected individual. Standard prophylactic dosage is 75 mg once daily for patients aged 13 and older, which has been shown to be safe and effective for up to six weeks.
![]()
No Comments »
No comments yet.
Fatal error: Call to undefined function: post_comments_feed_link() in /usr/home/drugrxus/domains/drugrxus.com/public_html/news/wp-content/themes/apple/comments.php on line 29